BridgeMD
New treatment option for Neuromuscular Blockade
Official title Deep Neuromuscular Blockade on Postoperative Pain
ClinicalTrials.gov ID: NCT06679569
What this study is testing
What is rocuronium 0.2 mg/kg/hr continuous infusion?
rocuronium 0.2 mg/kg/hr continuous infusion is an investigational medicine, given as an infusion into a vein, being studied as a potential treatment for neuromuscular blockade.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This study aims to investigate the impact of varying degrees of neuromuscular blockade on postoperative pain in pediatric patients aged over 2 months to under 7 years undergoing laparoscopic surgery under general anesthesia.
- Time commitment: about 2 months
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 2 to 7
You may be able to join if
- Pediatric patients aged over 2 months to under 7 years scheduled for laparoscopic surgery under general anesthesia.
- American Society of Anesthesiologists (ASA) Physical Status Classification I, II, or III.
You likely can't join if
- Patients undergoing emergency surgery.
- Patients with chronic pain or currently taking analgesics for chronic pain.
- Known hypersensitivity to general anesthetic agents or analgesics.
- Patients with underlying cardiovascular disease.
- Patients with neuromuscular disorders.
- Any other condition that, in the investigator's judgment, would make the patient unsuitable for participation in the study.
The study team makes the final eligibility decision.
Where it's taking place
- Seoul, Seoul, South Korea
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 2 months per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 2 months to 7 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Seoul, Seoul, South Korea. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.